ENTA will unveil preclinical data on its oral HBV RNA destablizer, EDP-721, at EASL: https://finance.yahoo.com/news/enanta-pharmaceuticals-present-preclinical-data-110000538.html Please see #msg-163654846 (bottom) for background info.